Blog
Class Action Lawsuit Claims OxyElite Pro Caused Liver Damage
Earlier this week – on Monday, January 27 – a class action lawsuit was filed against USPLabs, LLC, the manufacturer of purported dietary supplement OxyElite Pro. General Nutrition Center Holdings (GNC), a distributor for USPLabs, was also named as a defendant. The claim, filed in the U.S. District Court for the District of New…
Study Finds Risk of Heart Attack Doubles for Men Taking Testosterone
In the past few years, testosterone therapy has become increasingly popular – touted by both medical professionals and men with waning libidos or energy loss. According to a new study published in PLOS One, however, testosterone therapy was found to double the risk of heart attack in men over the age of 65. In…
Testosterone Replacement May Increase Risk of Stroke, Heart Attack, Death
A new study revealed that popular testosterone replacement products may boost risk of heart attack, stroke, and death. Low testosterone treatments are growing in popularity as testosterone manufacturers continue to drive aggressive marketing campaigns and advertising; however, men suffering from “low T” may want to consider the possible risks before getting a prescription. In…
Prenatal Exposure to SSRIs Could Increase Risk of Infant Pulmonary Hypertension, According to Recent BMJ Article
In an article published by BMJ earlier this week, the link between the use of certain serotonin reuptake inhibitors (SSRIs) during pregnancy and the later development of pulmonary hypertension in newborns was examined. The findings of the study identified an important association between late-pregnancy exposure to SSRIs and the statistical likelihood of pulmonary hypertension…
Risk of Liver Damage When Taking Doses of Acetaminophen Over 325mg
Are the pain relievers that you’ve been taking really as safe as they claim to be? At-home remedies such as Extra Strength Tylenol that contain acetaminophen are now being called into question by the United States Food and Drug Administration (FDA). As has been indicated by the FDA, the common ingredient in many pain…
FDA Warns Against Exceeding Recommended Doses of Over-the-Counter Sodium Phosphate Products for Constipation
In a warning issued last week, the United States Food and Drug Administration (FDA) suggested that the use of over-the-counter (OTC) sodium phosphate drugs for the treatment of constipation should not exceed the allotted dose per 24 hours. According to the FDA, rare but serious damage to the heart and kidneys can occur in…
Sexual Dysfunction in Male Patients Linked to ADHD Medication
According to an edition of Drug Safety that was published in August of 2013, Strattera (atomoxetine), an attention-deficit hyperactivity disorder (ADHD) medication, is known to cause side effects that include sexual dysfunction in male patients. The medication, which is a norepinephrine reuptake inhibitor (NRI), has been approved by the United States Food and Drug…
FDA Warns that Anti-Seizure Drug Poses Risk of Serious Skin Reactions
The United States Food and Drug Administration (FDA) has issued a warning against Onfi (clobazam), a popular anti-seizure drug that has been linked to incidents of serious skin reactions. Although rare, the skin reactions caused by the drug can cause permanent harm and even death in the worst case scenarios. Identified as the Stevens-Johnson…